Synlogic announces proposed public offering of common stock

Cambridge, mass., april 15, 2021 /prnewswire/ -- synlogic (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that it has commenced an underwritten public offering of its common stock.
SYBX Ratings Summary
SYBX Quant Ranking